Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for CureVac (CVAC) over the last 6 years, with Q3 2025 value amounting to -$1.5 million.

  • CureVac's Cash from Financing Activities rose 821.8% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year decrease of 82.71%. This contributed to the annual value of -$5.5 million for FY2024, which is 10219.98% down from last year.
  • As of Q3 2025, CureVac's Cash from Financing Activities stood at -$1.5 million, which was up 821.8% from -$1.5 million recorded in Q2 2025.
  • In the past 5 years, CureVac's Cash from Financing Activities ranged from a high of $455.7 billion in Q2 2021 and a low of -$432.6 billion during Q4 2021
  • Moreover, its 5-year median value for Cash from Financing Activities was -$1.3 million (2023), whereas its average is $1.2 billion.
  • Per our database at Business Quant, CureVac's Cash from Financing Activities crashed by 142383264.82% in 2021 and then skyrocketed by 14879.62% in 2023.
  • Quarter analysis of 5 years shows CureVac's Cash from Financing Activities stood at -$432.6 billion in 2021, then surged by 100.01% to $34.0 million in 2022, then tumbled by 104.46% to -$1.5 million in 2023, then increased by 9.85% to -$1.4 million in 2024, then dropped by 10.26% to -$1.5 million in 2025.
  • Its Cash from Financing Activities was -$1.5 million in Q3 2025, compared to -$1.5 million in Q2 2025 and -$1.4 million in Q1 2025.